Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2006
11/16/2006US20060257431 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
11/16/2006US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006US20060257424 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
11/16/2006US20060257423 Hepatitis B vaccine (HeVac) and Bacille Calmette-Guerin (BCG); cryoprotectants; lyophilization; heat stability; tuberculosis
11/16/2006US20060257419 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host
11/16/2006US20060257418 Vaccine
11/16/2006US20060257416 Materials and methods for improved vaccination
11/16/2006US20060257415 Adjuvants
11/16/2006US20060257414 Mycoplasma gallisepticum formulation
11/16/2006US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006US20060257372 Improvements in ruminants such as increased milk production, feedlot performance, growth rate, decrease in finishing time, lower digestive morbidity and mortality, lower incidence of lactic acidosis
11/16/2006US20060257329 Delivery of drug esters through an inhalation route
11/16/2006CA2609296A1 Nanoparticulate and controlled release compositions comprising a cephalosporin
11/16/2006CA2608326A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof
11/16/2006CA2608301A1 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof
11/16/2006CA2608061A1 Pharmaceutical composition including an anti-tumoral and an active ingredient selected among carveol, thymol, eugenol, borneol and carvacrol
11/16/2006CA2608058A1 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
11/16/2006CA2607806A1 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006CA2607617A1 Thiazole compounds and methods of use
11/16/2006CA2607561A1 Pharmaceutical composition
11/16/2006CA2607421A1 Thienopyrroles as antiviral agents
11/16/2006CA2607293A1 Use of tfpi to treat severe bacterial infections
11/16/2006CA2607145A1 Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
11/16/2006CA2607143A1 Delivery of tigecycline in the presence of heparin
11/16/2006CA2606890A1 Immunogens for meningitidis-a vaccines
11/16/2006CA2606887A1 Pharmaceutical composition
11/16/2006CA2606875A1 Pharmaceutical combination including an antibiotic and an active ingredient selected among carveol, thymol, carvacrol, alpha-ionone and beta-ionone
11/16/2006CA2606847A1 Antibacterial agents
11/16/2006CA2606507A1 Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
11/16/2006CA2586250A1 Compositions for treating respiratory viral infections and their use
11/15/2006EP1721987A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
11/15/2006EP1721981A1 Recombinant varicella-zoster virus
11/15/2006EP1721906A1 3-pyridinium methylcephem compound
11/15/2006EP1721901A1 Abc transporter inhibitor
11/15/2006EP1721898A1 Quinoline and pyridoquinoxaline derivatives as antibacterial agents
11/15/2006EP1721618A2 Proteosome influenza vaccine composition
11/15/2006EP1721614A1 Epirubicine hydrochloride for treating hepatitis C virus
11/15/2006EP1720899A2 Multimerised hiv fusion inhibitors
11/15/2006EP1720889A1 Sulfated oligosaccharide derivatives
11/15/2006EP1720876A1 Crystalline forms of valacyclovir hydrochloride
11/15/2006EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006EP1720578A2 Bacteriostatic esters for topical use
11/15/2006EP1720570A2 Treatment of dengue hemorrhagic fever
11/15/2006EP1720524A2 Extended release tablets of clarithromycin
11/15/2006EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006EP1363925B1 Macrolide antibiotics
11/15/2006EP1326610B1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
11/15/2006EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006EP1286696B1 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
11/15/2006EP1272197B1 Combination of lecithin with ascorbic acid
11/15/2006EP1254659B1 Stable emulsion compositions
11/15/2006EP1222281B1 Immunoligically significant herpes simplex virus antigens
11/15/2006EP1208214B1 Genetically engineered bleb vaccine
11/15/2006EP1132391B1 Process for the preparation of 3-sulfonyloxy-3-cephem compounds
11/15/2006EP1093363B1 Compositions for treatment of disorders associated with chlamydia
11/15/2006EP1039921B1 Substantially pure histidine-linked protein polymer conjugates
11/15/2006EP1009430B1 Oil in water emulsion vaccines against Hepatitis B
11/15/2006CN1864434A Wireless microphone communication system
11/15/2006CN1863813A Novel tricyclic nucleosides or nucleotides as therapeutic agents
11/15/2006CN1863812A Polymorphic antiviral nucleoside compounds
11/15/2006CN1863801A Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of HIV and inflammation
11/15/2006CN1863788A Substances of antimicrobial, antifungoid and antiprotozoan activities
11/15/2006CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes
11/15/2006CN1863535A Noncrystalline antibacterial composition containing cefditoren pivoxil
11/15/2006CN1863533A No title available
11/15/2006CN1863528A Indoles and azaindoles as antiviral agents
11/15/2006CN1863524A Neutralizing agent for cavitating toxin
11/15/2006CN1861634A Dog interferon alpha, preparation process and use thereof
11/15/2006CN1861626A Metallic salt kind medicine containing glycyrrhizic hypoglycyrrhizic or its derivant and preparation process thereof
11/15/2006CN1861623A Asparagic acid azithromycin and preparation thereof
11/15/2006CN1861622A Macrocyclolactone lactone kind medicine erythromycin A derivant, synthesizing process and use thereof
11/15/2006CN1861621A Process of preparing burdock glucoside and glucosidgen thereof
11/15/2006CN1861608A Crystalline solvate of cefuroxime acid
11/15/2006CN1861599A Quinone carboxylic acid kind derivant, it preparation process and medicine application
11/15/2006CN1861582A Cyclopropyl substituded triazol kind anti fungus compound and preparation process and use thereof
11/15/2006CN1861195A Fowl vaccine immunopotentiator of chicken interleuken-18, and its application
11/15/2006CN1861191A Application of human sDR5 protein as medicine to treat virus hepatitis B
11/15/2006CN1861189A Medicinal composition for eliminating infection and reduplication of influenza-virus
11/15/2006CN1861188A Aerosol contg. met-enkephalin
11/15/2006CN1861177A Medicinal composition for treating children cold and its prepn. process
11/15/2006CN1861131A Qingkailing dixinwan pill prepn. and its prepn. method
11/15/2006CN1861120A Oral liquor contg. Boehmeria nivea
11/15/2006CN1861107A Thin coating medicine for treating cold and its prepn. method
11/15/2006CN1861106A Compound isatis root effervescent tablet and its prepn. method
11/15/2006CN1861105A Traditional Chinese medicine used for treating human papillomavirus infection
11/15/2006CN1861092A Application of chlorine-contg. disinfectant in pharmaceutics
11/15/2006CN1861084A Compound fluorophenylnico injection, prepn. method and use thereof
11/15/2006CN1861079A Compounding prepn. contg. cefteram pivoxil and pidotimod
11/15/2006CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006CN1861065A Formula and prepn. method for compound ointment contg. zinc undecenate
11/15/2006CN1861062A Medicine composition used for fish or other aquatic livings and its prepn. method
11/15/2006CN1861044A Voriconazole injection and its prepn. method
11/15/2006CN1284854C Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy
11/15/2006CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006CN1284798C Poly thymosin-alpha 1, its composition, its preparation method and application
11/15/2006CN1284786C Glycyrrhetic acid and phospholipid composites of glycyrrhetate and process for preparing same
11/15/2006CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006CN1284763C Compound for preparing protease inhibitor